Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study

Authors

Felix Jacobs
Felix Lauffer (ORCID: https://orcid.org/0000-0002-1992-2836)
Dariusch Mortazawi
Tobias Hagemann
Blaine Gabriel Fritz (ORCID: https://orcid.org/0000-0002-2085-894X)
Ansgar Weyergraf (ORCID: https://orcid.org/0000-0001-5221-2492)
Thomas Mosch
Stephan Weidinger (ORCID: https://orcid.org/0000-0003-3944-252X)
Tobias Schadeck
Fatima Abousamra

Institutions

Hamm-Lippstadt University of Applied Sciences (DE)
Leiber (Germany) (DE)
University Hospital Schleswig-Holstein (DE)
AbbVie (Germany) (DE)
Ludwig-Maximilians-Universität München (DE)
University of Lübeck (DE)

Publication Details

Journal: Dermatology and Therapy
Published: 2025-03-15
DOI: https://doi.org/10.1007/s13555-025-01373-7
Citations: 6
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 12.03

Funders

AbbVie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study

Felix Jacobs, Felix Lauffer, Dariusch Mortazawi, Tobias Hagemann et al.

Mar 15, 2025

6 citations

Dermatology and Therapy

Dermatology and Skin Diseases

12.03

article

Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study

Felix Jacobs, Felix Lauffer, Dariusch Mortazawi, Tobias Hagemann, Blaine Gabriel Fritz, Ansgar Weyergraf, Thomas Mosch, Stephan Weidinger, Tobias Schadeck, Fatima Abousamra

March 15, 2025article en

6 citations

Abstract

No abstract available for this paper.

Dermatology and TherapyVol. 15(4)

Hamm-Lippstadt University of Applied Sciences (DE), Leiber (Germany) (DE), University Hospital Schleswig-Holstein (DE), AbbVie (Germany) (DE), Ludwig-Maximilians-Universität München (DE), University of Lübeck (DE)

AbbVie

Openalex Percentile: Top 2%

Dermatology and Skin Diseases

12.03

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.